SI-BONE is the developer of the iFuse Implant System, a minimally invasive surgical treatment for sacroiliac (SI) joint disorders.
iFuse Implant System is intended for SI fusion for the following conditions:
- SI joint dysfunction that is a direct result of SI joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months.
- To augment stabilization and immobilization of the SI joint in skeletally mature patients undergoing sacropelvic fixation as part of a lumbar or thoracolumbar fusion.
- Acute, non-acute, and non-traumatic fractures involving the SI joint.
There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: www.si-bone.com/risks